Mostrar el registro sencillo del ítem
Oxidative stress and lung ischemia-reperfusion injury
dc.contributor.author | Ferrari, Renata Salatti | pt_BR |
dc.contributor.author | Andrade, Cristiano Feijó | pt_BR |
dc.date.accessioned | 2019-05-11T02:37:45Z | pt_BR |
dc.date.issued | 2015 | pt_BR |
dc.identifier.issn | 1942-0994 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/194148 | pt_BR |
dc.description.abstract | Ischemia-reperfusion (IR) injury is directly related to the formation of reactive oxygen species (ROS), endothelial cell injury, increased vascular permeability, and the activation of neutrophils and platelets, cytokines, and the complement system. Several studies have confirmed the destructiveness of the toxic oxygen metabolites produced and their role in the pathophysiology of different processes, such as oxygen poisoning, inflammation, and ischemic injury. Due to the different degrees of tissue damage resulting fromthe process of ischemia and subsequent reperfusion, several studies in animal models have focused on the prevention of IR injury and methods of lung protection. Lung IR injury has clinical relevance in the setting of lung transplantation and cardiopulmonary bypass, for which the consequences of IR injury may be devastating in critically ill patients. | en |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | Oxidative Medicine and Cellular Longevity. New York. Volume 2015 (2015), ID 590987, 14 p. | pt_BR |
dc.rights | Open Access | en |
dc.subject | Traumatismo por reperfusão | pt_BR |
dc.subject | Estresse oxidativo | pt_BR |
dc.subject | Lesão pulmonar | pt_BR |
dc.subject | Permeabilidade capilar | pt_BR |
dc.title | Oxidative stress and lung ischemia-reperfusion injury | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dc.identifier.nrb | 000977261 | pt_BR |
dc.type.origin | Estrangeiro | pt_BR |
Ficheros en el ítem
Este ítem está licenciado en la Creative Commons License
-
Artículos de Periódicos (40361)Ciencias de la Salud (10795)